Andrew Stewart Plump
Director, President, R&D · 3 filings · Latest: Aug 10, 2026
TAKEDA PHARMACEUTICAL CO LTD
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
TAK | Andrew Stewart Plump | Director, President, R&D | Aug 10, 2026 | Sale | $17.10 | 165,393 | $2.8M | 766,569 | |
TAK | Andrew Plump | — | Jul 13, 2026 | Proposed Sale | $16.75 | 179,239 | $3.0M | — | |
TAK | Andrew Plump | — | Jul 9, 2025 | Proposed Sale | $15.42 | 169,313 | $2.6M | — | |